Patents by Inventor Dirk M. Anderson

Dirk M. Anderson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RANK LIGAND POLYPEPTIDES
    Publication number: 20140235832
    Abstract: Described herein are kits for use in detecting RANKL polypeptides.
    Type: Application
    Filed: May 2, 2014
    Publication date: August 21, 2014
    Applicant: IMMUNEX CORPORATION
    Inventor: Dirk M. ANDERSON
  • RECEPTOR ACTIVATOR OF NF-kappaB
    Publication number: 20140186887
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Application
    Filed: October 28, 2013
    Publication date: July 3, 2014
    Applicant: IMMUNEX CORPORATION
    Inventor: DIRK M. ANDERSON
  • METHOD OF INHIBITING OSTEOCLAST ACTIVITY
    Publication number: 20140178376
    Abstract: Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
    Type: Application
    Filed: August 26, 2013
    Publication date: June 26, 2014
    Applicant: IMMUNEX CORPORATION
    Inventors: Dirk M. ANDERSON, Laurent J. GALIBERT
  • RANK ligand polypeptides
    Patent number: 8715683
    Abstract: Described herein are cell lines and methods for preparing antibodies that bind RANKL, including cell lines that produce blocking antibodies to human RANKL.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: May 6, 2014
    Assignee: Immunex Corporation
    Inventor: Dirk M Anderson
  • Receptor activator of NF-kappaB
    Patent number: 8569456
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Grant
    Filed: March 19, 2012
    Date of Patent: October 29, 2013
    Assignee: Immunex Corporation
    Inventors: Dirk M Anderson, Laurent Galibert, Eugene Maraskovsky
  • Cells and methods for producing blocking antibodies to human RANKL
    Patent number: 8377690
    Abstract: Described herein are cell lines and methods for preparing antibodies that bind RANKL, including cell lines that produce blocking antibodies to human RANKL.
    Type: Grant
    Filed: June 15, 2010
    Date of Patent: February 19, 2013
    Assignee: Immunex Corporation
    Inventor: Dirk M Anderson
  • Method of inhibiting osteoclast activity
    Patent number: 8333963
    Abstract: Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
    Type: Grant
    Filed: August 4, 2010
    Date of Patent: December 18, 2012
    Assignee: Immunex Corporation
    Inventors: Dirk M Anderson, Laurent J Galibert
  • RECEPTOR ACTIVATOR OF NF-kappaB
    Publication number: 20120178912
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Application
    Filed: March 19, 2012
    Publication date: July 12, 2012
    Applicant: IMMUNEX CORPORATION
    Inventors: Dirk M. ANDERSON, Laurent GALIBERT, Eugene MARASKOVSKY
  • Kits for detecting rank
    Patent number: 8153775
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Grant
    Filed: April 22, 2011
    Date of Patent: April 10, 2012
    Assignee: Immunex Corporation
    Inventor: Dirk M Anderson
  • Cell lines producing blocking antibodies to human RANKL
    Publication number: 20120034690
    Abstract: Described herein are cell lines and methods for preparing antibodies that bind RANKL, including cell lines that produce blocking antibodies to human RANKL.
    Type: Application
    Filed: June 15, 2010
    Publication date: February 9, 2012
    Applicant: IMMUNEX CORPORATION
    Inventor: Dirk M. Anderson
  • RECEPTOR ACTIVATOR OF NF kappa-B
    Publication number: 20110200990
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Application
    Filed: April 22, 2011
    Publication date: August 18, 2011
    Applicant: IMMUNEX CORPORATION
    Inventor: Dirk M. ANDERSON
  • Kits for detecting rank nucleic acids
    Patent number: 7932375
    Abstract: Isolated receptors, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response. The receptors are also useful in screening for inhibitors thereof.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: April 26, 2011
    Assignee: Immunex Corporation
    Inventor: Dirk M Anderson
  • ATTRACTIN/MAHOGANY-LIKE POLYPEPTIDES, POLYNUCLEOTIDES, ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20110091469
    Abstract: The present disclosure provides attractin/mahogany-like polypeptides and fragments thereof, polynucleotides encoding such polypeptides and fragments, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides or fragments, and assays and methods employing these polypeptides, antibodies, and polynucleotides.
    Type: Application
    Filed: December 22, 2010
    Publication date: April 21, 2011
    Applicant: Immunex Corporation
    Inventor: Dirk M. Anderson
  • METHOD OF INHIBITING OSTEOCLAST ACTIVITY
    Publication number: 20110086033
    Abstract: Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
    Type: Application
    Filed: August 4, 2010
    Publication date: April 14, 2011
    Applicant: IMMUNEX CORPORATION
    Inventors: Dirk M. ANDERSON, Laurent J. GALIBERT
  • Attractin/mahogany-like polypeptides
    Patent number: 7893204
    Abstract: The present disclosure provides attractin/mahogany-like polypeptides and fragments thereof, polynucleotides encoding such polypeptides and fragments, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides or fragments, and assays and methods employing these polypeptides, antibodies, and polynucleotides.
    Type: Grant
    Filed: April 22, 2008
    Date of Patent: February 22, 2011
    Assignee: Immunex Corporation
    Inventor: Dirk M. Anderson
  • LIR-9, a novel leukocyte immunoglobulin-like receptor
    Patent number: 7875703
    Abstract: A new family of immunoreceptor molecules of the immunoglobulin superfamily, (LIR) polypeptides is described. Disclosed are sequences encoding LIR family members and their deduced amino acid sequences, polypeptides encoded by DNA that hybridizes to defined nucleotide sequences, processes for producing polypeptides of the LIR family, and specific antibodies directed against LIR polypeptides. LIR family members can be used to treat autoimmune diseases and disease states associated with suppressed immune function.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: January 25, 2011
    Assignee: Immunex Corporation
    Inventors: Dirk M. Anderson, Luis G. Borges
  • Interleukin-15 receptors
    Patent number: 7863019
    Abstract: There are disclosed Interleukin-15 Receptor (IL-15R) proteins, DNAs and expression vectors encoding IL-15R, and processes for producing IL-15R as products of recombinant cell cultures.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: January 4, 2011
    Assignee: Immunex Corporation
    Inventors: Dirk M. Anderson, Judith G. Giri
  • Method of inhibiting osteoclast activity
    Patent number: 7790684
    Abstract: Methods for inhibiting osteoclastogenesis by administering a soluble RANK polypeptide are disclosed. Such methods can be used to treat a variety of different cancers, including bone cancer, multiple myeloma, melanoma, breast cancer, squamous cell carcinoma, lung cancer, prostate cancer, hematologic cancers, head and neck cancer and renal cancer.
    Type: Grant
    Filed: June 11, 2008
    Date of Patent: September 7, 2010
    Assignee: Immunex Corporation
    Inventors: Dirk M. Anderson, Laurent J. Galibert
  • Methods for interfering with rank signaling
    Patent number: 7744886
    Abstract: Disclosed herein are methods for interfering with RANK signaling by administering blocking antibodies that bind a RANKL polypeptide and inhibit the binding of the RANKL polypeptide to a RANK polypeptide.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: June 29, 2010
    Assignee: Immunex Corporation
    Inventor: Dirk M Anderson
  • Antibodies binding to human ataxin-1-like polypeptide
    Patent number: 7704501
    Abstract: This invention relates to IMX97018, a new members of the human ataxin-1-like polypeptide family, methods of making such polypeptides, and to methods of using them to diagnose and treat neurological conditions and to identify compounds that alter IMX97018 polypeptide activities.
    Type: Grant
    Filed: November 2, 2006
    Date of Patent: April 27, 2010
    Assignee: Immunex Corporation
    Inventor: Dirk M. Anderson